Etubics Corporation (Etubics)

Oncology Corporate Profile

HQ Location

410 West Harrison Street, Suite 100
Seattle, WA 98119

Company Description

Etubics Corporation is a clinical stage biotechnology company focused on developing immunotherapeutics for the treatment of cancer and vaccines against infectious diseases. The Company has a pipeline of product candidates based on our proprietary, advanced generation viral vector platform the Etubics Platform to generate both T cell mediated and antibody responses and its complimentary manufacturing human-based cell line.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
ETBX-011immunotherapyColorectal cancerII
ETBX-011immunotherapyBreast cancerPreclinical
ETBX-011immunotherapyHead & Neck cancerPreclinical

View additional information on product candidates here »


Recent News Headlines

There are no news items to display